{"url":"https://lda.senate.gov/api/v1/filings/b172280d-5aee-4117-8e1a-e56e4bb48a99/","filing_uuid":"b172280d-5aee-4117-8e1a-e56e4bb48a99","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b172280d-5aee-4117-8e1a-e56e4bb48a99/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jill Robinson","dt_posted":"2020-03-10T17:42:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"470 Atlantic Avenue","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02210","registrant":{"id":401105530,"url":"https://lda.senate.gov/api/v1/registrants/401105530/","house_registrant_id":null,"name":"MORPHOSYS US INC.","description":"Biopharmaceuticals","address_1":"470 Atlantic Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02210","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVEN SCHELLINGS","contact_telephone":"+1 202-999-5936","dt_updated":"2022-05-27T13:50:51.059793-04:00"},"client":{"id":205668,"url":"https://lda.senate.gov/api/v1/clients/205668/","client_id":12,"name":"MORPHOSYS US INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the biopharmaceutical industry.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":72828,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":"Director of Legislative Affairs, National Security Council, The White House","new":true},{"lobbyist":{"id":72833,"prefix":null,"prefix_display":null,"first_name":"JENN","nickname":null,"middle_name":null,"last_name":"GRUBER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":108014,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"MANCILL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"MORPHOSYS AG","contribution":"0.00","ownership_percentage":"100.00","address":"Semmelweisstr. 7","city":"Planegg","state":null,"state_display":null,"country":"DE","country_display":"Germany","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"DE","ppb_country_display":"Germany"}],"affiliated_organizations":[]}